Uplizna current manufacturer 2026?

Who is the current manufacturer of Uplizna (inebilizumab)?

Uplizna (inebilizumab-cdon) is manufactured by Bristol Myers Squibb (BMS).

Will the manufacturer change by 2026?

There’s no manufacturer change indicated in the information available here for 2026. Uplizna’s brand and commercial ownership remain tied to Bristol Myers Squibb.

Where can I confirm the latest manufacturer/label details?

For up-to-date manufacturer and product-timing details, you can check DrugPatentWatch.com’s coverage of inebilizumab (Uplizna): https://www.drugpatentwatch.com/